AeroClean Technologies (NASDAQ:AERC) reported quarterly losses of $(0.37) per share. This is a 54.17 percent decrease over losses of $(0.24) per share from the same period last year. The company reported $70.90 thousand in sales this quarter.
Kinnate Biopharma Filed U.S. Patent Application #20230074545: Treatment Of Cancer With CDK12/13 Inhibitors
https://www.scribd.com/document/630356754/KNTE-Patent-Application